LaurenMiller Forbes

Of Counsel

華盛頓 + 1.202.879.3798

Lauren Miller Forbes practices antitrust and competition law, focusing on mergers, nonmerger investigations, and antitrust counseling. She has represented clients from a broad range of industries — including aviation, home products, semiconductors, building materials, pharmaceuticals, and medical devices — before the U.S. Department of Justice (DOJ), the Federal Trade Commission (FTC), and state antitrust enforcers.

Lauren counsels buyers and sellers in domestic and international transactions at every stage of the deal process, from premerger planning to regulatory filings, DOJ and FTC investigations, and litigation. She served as antitrust counsel to General Electric in its $3.4 billion sale of GE Water & Process Technologies to Suez, Tokyo Electron in its proposed merger with Applied Materials, and Baxter International's successful acquisition of generic pharmaceuticals company Claris Injectables; she also defended Electrolux Corporation in DOJ's challenge to the proposed acquisition of General Electric's appliance business.

Lauren advises clients on a wide range of merger and nonmerger topics, including competitor collaborations, monopolization claims, and potential government investigations. She has successfully defended a building materials manufacturer against price-fixing claims levied by both private plaintiffs and government enforcers and advised a medical device manufacturer on monopolization issues. She has also conducted internal investigations and developed antitrust compliance programming for major automotive, pharmaceutical, and consumer goods clients.

Lauren is a member of the American Bar Association's Section of Antitrust Law and writes regularly on antitrust issues for that organization. She is also a member of the Virginia State Bar and the District of Columbia Bar.


  • Labcorp completes spin-off of FortreaJones Day represented Labcorp (NYSE: LH), a leading global life sciences company, in the spin-off of Fortrea, the newly formed independent Contract Research Organization providing Phase I-IV clinical trial management, market access and technology solutions to pharmaceutical and biotechnology organizations around the world.
  • AAR acquires TraxJones Day advised AAR CORP. in the acquisition of Trax USA Corp., a leading independent provider of aircraft MRO and fleet management software, for a purchase price of $120 million in cash, plus up to a $20 million earn-out payment based on specified adjusted revenues in calendar year 2023 and 2024.
  • Meridian Bioscience agrees to be acquired by SD Biosensor and SJL Partners in $1.53 billion all-cash transactionJones Day advised Meridian Bioscience, Inc. in its $1.53 billion all-cash acquisition by SD Biosensor and SJL Partners.
  • Parker divests its Aircraft Wheel and Brake divisionJones Day advised Parker-Hannifin Corporation (NYSE: PH, “Parker”), the global leader in motion and control technologies, in the divestiture of its Aircraft Wheel and Brake Division, located in Avon, Ohio, to Kaman Corporation (NYSE: KAMN) for $440 million.
  • Signature Aviation sells TAC Air FBOs to Atlantic AviationJones Day advised Signature Aviation in its divestiture of three TAC Air fixed base operations at Omaha, Nebraska (OMA); Raleigh-Durham, North Carolina (RDU); and Hartford, Connecticut (BDL) to Atlantic Aviation.
  • Signature Aviation acquires 14 TAC Air locations Jones Day advised Signature Aviation in the acquisition of the TAC Air business of The Arnold Companies.
  • Monster Beverage acquires CANarchyJones Day advised Monster Beverage Corporation in the $330 million acquisition of CANarchy Craft Brewery Collective LLC, a craft beer and hard seltzer company.
  • City of Hope acquires Cancer Treatment Centers of AmericaJones Day advised City of Hope, a world-renowned, National Cancer Institute (NCI)-designated comprehensive cancer research and treatment organization, in connection with its acquisition of Cancer Treatment Centers of America, a network of oncology hospitals and outpatient care centers across the United States.
  • Misonix merges with BioventusJones Day represented Misonix, Inc. (Nasdaq: MSON) in its acquisition by Bioventus Inc. (Nasdaq: BVS).
  • Milliken & Company acquires Encapsys, LLCJones Day advised Milliken & Company in its acquisition of Encapsys, LLC, a world leader in microencapsulation delivery systems for the building, construction, paper, bedding and personal care industries.
  • DMI secures strategic investment from OceanSound PartnersJones Day advised DMI in its strategic investment from an affiliate of OceanSound Partners, LP.
  • Eaton sells hydraulics business to DanfossJones Day advised Eaton Corporation as antitrust counsel in the sale of its hydraulics business to Danfoss Power Solutions for US$3.3 billion.
  • Signature Aviation sells Global Engine Services business to StandardAero for $230 millionJones Day advised Signature Aviation plc, a market-leading provider of global aviation support services, in the $230 million sale of the Engine Repair and Overhaul (ERO) business to StandardAero, a portfolio company owned by The Carlyle Group and a leading provider of maintenance, repair, and overhaul services.
  • OMNOVA acquired by Synthomer plc for $824 millionJones Day advised OMNOVA Solutions Inc. in its $824 million acquisition by Synthomer plc, a United Kingdom-based specialty chemical company.
  • BBA Aviation sells Ontic for $1.365 billionJones Day advised BBA Aviation plc ("BBA") in the sale of its Ontic business to an investment fund affiliated with CVC Capital Partners for $1.365 billion.
  • Milliken & Company acquires PolartecJones Day advised Milliken & Company in its acquisition of Polartec, a strong global brand known for its innovative performance textiles for outdoor and military apparel, from Versa Capital Management, LLC.
  • Yale New Haven Health adds Milford Health & Medical to its health systemJones Day served as antitrust counsel to Yale New Haven Health System regarding its Bridgeport Hospital’s successful acquisition of Milford Health & Medical, Inc., an acute care community hospital located in Milford, Connecticut.
  • Milliken & Company acquires Andover Healthcare, Inc. and Andover Resources, Inc.Jones Day advised Milliken & Company, an industrial manufacturer that is active in a breadth of disciplines, including specialty chemical, floor covering, performance and protective textile materials, in connection with the acquisition of Andover Healthcare, Inc. and Andover Resources, Inc., leading manufacturers of cohesive bandages and tapes for healthcare, animal health, and sports medicine industries.
  • Newell Brands sells Process Solutions to One Rock Capital Partners, LLC for $500 millionJones Day advised Newell Brands Inc. in the sale of its Process Solutions business to One Rock Capital Partners, LLC for $500 million in cash.
  • USG acquired by Gebr. Knauf for $7 billionJones Day advised USG Corporation in the acquisition by Gebr. Knauf KG ("Knauf") of all of the outstanding shares of USG in a transaction valued at $7 billion.
  • 著作

    • May 2021
      U.S. Antitrust Law Developments chapter in Report on Competition Law and Policy of China (2020), China World Trade Organization Studies
    • May 2020
      U.S. Antitrust Law Developments chapter in Report on Competition Law and Policy of China (2019), China World Trade Organization Studies
    • August 2018
      Structural Remedies, Global Competition Review, The Guide to Merger Remedies
    • April 9, 2018
      Chapter XII: Antitrust Division Relationships with State Attorneys General (contributing editor), DOJ Civil Antitrust Practice and Procedure Manual, Second Edition

    • May 6, 2020
      Co-Moderator, Lessons from the Field: The Evonik Litigation, W@ B3 Initiative